Regulation A · Tier 2
GOA Therapeutics Corp
GOA Therapeutics Corp filed a Tier 2 Regulation A offering statement (Form 1-A) on Sep 15, 2026 for up to $75M at $15.00 per security. The SEC qualified the offering on Oct 13, 2026. Underwriter or broker: D, e and a.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $75M
- Offer price
- $15.00
- Security type
- Equity (common or preferred stock)
- Filed
- Sep 15, 2026
- Qualified
- Oct 13, 2026
- Industry
- Pharmaceutical Preparations
- State
- FL
- Underwriter / broker
- D, e, a, l, M, k, r, S, c, u, i, t, s, L and C
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Sep 15, 2026
- Final offering circular (253G2)
- All filings on EDGAR CIK 2131824
Other qualified Biotech & pharma Reg A offerings
- CBD Life Sciences Inc.Jun 8, 2026 · $670K
- Bio-Path Holdings, Inc.Apr 28, 2026 · $600K
- Cannabis Bioscience International Holdings, Inc.Apr 13, 2026 · $2.5M
- Niihara International, Inc.Feb 6, 2026 · $20M
- Dare Bioscience, Inc.Jan 5, 2026 · $24.3M
- Bio Essence CorpJan 5, 2026 · $5M